EtCin was found grafted in the 0.3 1.0 mol% range when the binary system MAH/EtCin was applied.
We found that graft copolymers with less cationic peptides and less grafting density formed colloidally stable polyplexes.
We found the graft patent by computed tomography in 3 months after the surgery.
No interference was found between graft tunneling and the anchor side for the subscapularis tenodesis.
We found that graft cells from donor's peripheral blood, either allogeneic or autologous, were enriched for central memory, effector memory and effector phenotypes compared to allogeneic bone marrow grafts, as assessed by surface markers phenotyping and granzyme B expression.
A significant interaction was found between graft type and reduced-intensity conditioning regimen.
At 6-month follow-up, no significant differences between both techniques were found in graft patency and mortality.
Although graft manipulation differed between cancer patients (un-manipulated) and RA (CD34 selected ± T-cell depletion) as mentioned above, we found that graft manipulation did not affect the rate of reconstitution in RA patients (data not shown).
In the present study, we have found a graft survival rate of 93.9% at 1 year, 81.5% at 5 years, and 67.6% at the end of the study and the patient survival rates were 97.9% at 1 and 5 years and 91.4% at the end of the study.
The AFM observation illuminated that circles one by one were formed in "grafting from" prepared SiO2 (GF), while core shell morphology found in "grafting to" prepared SiO2 (GT), because of the different surface properties of the modified SiO2.
